Revive Therapeutics Ltd (RVVTF)

[LT 1990]

News last Friday was promising, cleared the air for sure, study continues. Enrollment is likely the problem I gather based on the cnn article. Boulware only able to get 300 pts out of 1000, hence the expansion of up to 50 sites. However we’ve got 210 for 1000 done with four interm points so hopefully the independent dsmb will get this unblinded after 400 if efficacy is clearly undeniable, I’m going to put my expectations closer to 600 unblinding and submit for EUA approval
in May. Cydy trial for ph 3 was only 397 pts but also impatient. Good news regardless, headed in the Right direction I think we can count on 600 and submission in May. Pr was vague on when we hit 210 and how many we have. Don’t know why that’s a secret. Overall happy to hear “planned completion and approaching Fda for EUA”s accumulate and wait till May